Back to Awarded Treatment Trials


Awarded Trial: 15T-001

Grant ID

15T-001

Illness

Schizophrenia

Primary Drug/Intervention

Sulforaphane Nutraceutical

Primary Dosage

100 umol per day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Faith Dickerson, PhD

Sample Size

64

Duration of Study Period for Each Subject

126 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Faith Dickerson

Degree

PhD

Center

N/A

Institution

Sheppard Pratt

Address

N/A

City or Town

Baltimore

State or Province

MD

Zip or Postal Code

N/A

Country

USA

Email Address

fdickerson@sheppardpratt.org